Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (EMT) markers for prognosis in high‐risk non‐muscle‐invasive (HGT1) bladder cancer

• 主要な著者: Edward C Ottley (著者), Robert Pell (著者), Benedict Brazier (著者), Julianne Hollidge (著者), Christiana Kartsonaki (著者), Lisa Browning (著者), Eric O'Neill (著者), Anne E Kiltie (著者)
• フォーマット: 図書
• 出版事項: Wiley, 2020-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Approximately 75% of bladder cancers are non‐muscle invasive (NMIBC). Of these, up to 53% of cases progress to life‐threatening muscle‐invasive bladder cancer (MIBC). Patients with high‐grade stage T1 (HGT1) NMIBC frequently undergo radical cystectomy (RC), although this represents overtrea...